Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

How blocking an immune system response could improve heart attack survival

December 15, 2017 By Danielle Kirsh

immune system

Myocardial infarction activates IRF3-dependent signaling. [Image from UCSD]

California researchers have discovered that the immune system’s response after a heart attack plays a significant role in what happens following a heart attack.

Following a heart attack, heart cells begin to die, causing the immune system to send immune cells into the dead tissue to clear debris and start stabilizing the heart wall. University of California San Diego researchers wanted to figure out why dying cells in the heart create an immune system response.

Researchers examined individual cardiac immune cslls and mapped the individual transcriptomes using single cell RNA sequencing. During the examination, they discovered that the DNA from dying cells appears similar to a virus after a heart attack. An ancient antiviral program in the immune system called type I interferon is triggered in special immune cells when it notices the “virus.” The researchers named them interferon inducible cells (IFNICs).

The researchers blocked interferon response genetically or with a neutralizing antibody administered after a heart attack. They found that there was less inflammation, less heart dysfunction and improved survival. They also noted that blocking antiviral responses in mice was shown to improve survival from 60% to over 95%, suggesting that this could be a potential therapeutic option to prevent heart attacks from causing heart failure in the future.

“We are interested to learn whether interferons contribute to adverse cardiovascular outcomes after heart attacks in humans,” Kevin King, a bioengineer and physician at UCSD and researcher on the study, said in a press release.

Over time, the immune system has evolved natural antiviral programs to protect the body from a wide variety of invading pathogens. Immune cells detect molecular fingerprints of pathogens and activate the IRF3 protein while secreting interferons to create a defense program for hundreds of interferon-stimulated genes.

The antiviral interferon response is activated after a heart attack, according to the researchers, even though there is no infection. They found that dying cell DNA causes the immune system to think that there is an infection.

A previously unrecognized subset of cardiac macrophages were part of the immune cells in the interferon response. The cells were unable to be identified by flow sorting due to its unknown unique markers on the cell surface. Using single-cell RNA sequencing, the UCSD researchers could see the expressions of every gene in over 4,000 cardiac immune cells and could find the specialized IFNIC population of responsible cells.

More research is planned to get a better understanding of the interferon response and the IFNIC cell type to figure out what role they play in remodeling the heart. The researchers are also working on understanding the interferon response in other tissues and disease that result in cell death.

The research was published in the journal Nature Medicine.

About The Author

Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Related Articles Read More >

Illustration of MIT’s bone-anchored bionic knee: powered prosthetic leg, amputee using the device to walk and step over an obstacle, and cross-sections of thigh muscles showing electrodes and a titanium implant connecting nerves and bone.
Bionic knee wired to muscle nerves helps amputees clear obstacles, climb stairs
Carnegie Mellon University EEG-based BCI to control robotic hand
Non-invasive BCI enables robotic hand dexterity
Digital twins
How digital twins could advance cancer care
MassGeneralBrigham
Mass General Brigham research finds pulse rate could predict cognitive decline
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe